Naturally circulating dendritic cells to vaccinate cancer patients

K.F. Bol, J. Tel, I.J.M. de Vries, C.G. Figdor

Research output: Contribution to journalArticleAcademicpeer-review

22 Citations (Scopus)


Dendritic cell-based immunotherapy is a promising strategy against cancer that appears to be feasible, safe and to induce potent tumor-specific immune responses. The use of naturally circulating dendritic cells (DCs), rather than cultured monocyte-derived DCs, might constitute the next logical step to translate anticancer immune responses into long-lasting clinical benefits.

Original languageEnglish
Article numbere23431
Issue number3
Publication statusPublished - 1 Mar 2013
Externally publishedYes


Dive into the research topics of 'Naturally circulating dendritic cells to vaccinate cancer patients'. Together they form a unique fingerprint.

Cite this